Literature DB >> 23397632

Role of P-glycoprotein at the blood-testis barrier on adjudin distribution in the testis: a revisit of recent data.

Linlin Su1, Pranitha Jenardhanan, Dolores D Mruk, Premendu P Mathur, Yan-Ho Cheng, Ka-Wai Mok, Michele Bonanomi, Bruno Silvestrini, C Yan Cheng.   

Abstract

The blood-testis barrier (BTB) is one of the tightest blood-tissue barriers in mammals including rodents and humans. It is used to sequester meiosis I and II, postmeiotic spermatid development via spermiogenesis and the release of sperm at spermiation from the systemic circulation, such that these events take place in an immune-privileged site in the adluminal (apical) compartment behind the BTB, segregated from the host immune system. Additionally, drug transporters, namely efflux (e.g., P-glycoprotein) and influx (e.g., Oatp3) pumps, many of which are integral membrane proteins in Sertoli cells at the BTB also work cooperatively to restrict the entry of drugs, toxicants, chemicals, steroids and other xenobiotics into the adluminal compartment. As such, the BTB that serves as an important physiological and selective barrier to protect germ cell development also poses a "hurdle" in male contraceptive development. For instance, adjudin, 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide, a potential nonhormonal male contraceptive that exerts its effects on germ cell adhesion, most notably at the Sertoli cell-spermatid interface, to induce "premature" germ cell loss from the seminiferous epithelium mimicking spermiation, has a relatively poor bioavailability largely because of the BTB. Since male contraceptives (e.g., adjudin) will be used by healthy men for an extended period of his life span after puberty, a better understanding on the BTB is necessary in order to effectively deliver drugs across this blood-tissue barrier in particular if these compounds exert their effects on developing germ cells in the adluminal compartment. This can also reduce long-term toxicity and health risk if the effective dosing can be lowered in order to widen the margin between its safety and efficacy. Herein, we summarize latest findings in this area of research, we also provide a critical evaluation on research areas that deserve attention in future studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23397632      PMCID: PMC4114387          DOI: 10.1007/978-1-4614-4711-5_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  38 in total

Review 1.  Drug transporters in drug efficacy and toxicity.

Authors:  M K DeGorter; C Q Xia; J J Yang; R B Kim
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-19       Impact factor: 13.820

Review 2.  Delivering non-hormonal contraceptives to men: advances and obstacles.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Trends Biotechnol       Date:  2008-01-11       Impact factor: 19.536

3.  Identification of putative binding sites of P-glycoprotein based on its homology model.

Authors:  Christoph Globisch; Ilza K Pajeva; Michael Wiese
Journal:  ChemMedChem       Date:  2008-02       Impact factor: 3.466

Review 4.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

Review 5.  AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data.

Authors:  C Yan Cheng; Dolores Mruk; Bruno Silvestrini; Michele Bonanomi; Ching-Hang Wong; Michelle K Y Siu; Nikki P Y Lee; Wing-Yee Lui; Meng-Yun Mo
Journal:  Contraception       Date:  2005-10       Impact factor: 3.375

6.  An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model.

Authors:  Erica R Siu; Elissa W P Wong; Dolores D Mruk; K L Sze; Catarina S Porto; C Yan Cheng
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

7.  PDBsum new things.

Authors:  Roman A Laskowski
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

Review 8.  Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.

Authors:  Tarek Boutros; Eric Chevet; Peter Metrakos
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

9.  Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.

Authors:  Stephen G Aller; Jodie Yu; Andrew Ward; Yue Weng; Srinivas Chittaboina; Rupeng Zhuo; Patina M Harrell; Yenphuong T Trinh; Qinghai Zhang; Ina L Urbatsch; Geoffrey Chang
Journal:  Science       Date:  2009-03-27       Impact factor: 47.728

10.  Focal adhesion kinase is a blood-testis barrier regulator.

Authors:  Erica R Siu; Elissa W P Wong; Dolores D Mruk; Catarina S Porto; C Yan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-21       Impact factor: 11.205

View more
  6 in total

Review 1.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

2.  Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.

Authors:  Cindy Yanfei Li; Abdul Basit; Anshul Gupta; Zsuzsanna Gáborik; Emese Kis; Bhagwat Prasad
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-05       Impact factor: 4.292

Review 3.  Use of Molecular Modeling to Study Spermatogenesis: An Overview Using Proteins in Sertoli Cells.

Authors:  Pranitha Jenardhanan; Manivel Panneerselvam; Premendu P Mathur
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The apical ES-BTB-BM functional axis is an emerging target for toxicant-induced infertility.

Authors:  Hin-Ting Wan; Dolores D Mruk; Chris K C Wong; C Yan Cheng
Journal:  Trends Mol Med       Date:  2013-05-02       Impact factor: 11.951

5.  Localization of multidrug resistance-associated proteins along the blood-testis barrier in rat, macaque, and human testis.

Authors:  David M Klein; Stephen H Wright; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

6.  In silico Analysis for Predicting Fatty Acids of Black Cumin Oil as Inhibitors of P-Glycoprotein.

Authors:  Babar Ali; Qazi Mohd Sajid Jamal; Showkat R Mir; Saiba Shams; Naser A Al-Wabel; Mohammad A Kamal
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.